Antibody Drug Conjugates (ADCs) Market Insights 2026: Precision Oncology Transformation
The landscape of cancer treatment is undergoing a seismic shift. Gone are the days when "scorched earth" chemotherapy was the only viable path for late-stage patients. Today, we are living in the era of the "magic bullet" , a concept first envisioned by Paul Ehrlich over a century ago now realized through the Antibody Drug Conjugates (ADCs) Market. By combining the laser-like precision of...
0 Commentarios 0 Acciones 83 Views 0 Vista previa